Related Experiment Video
Updated: Apr 30, 2026

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
Microvascular anastomosis using Ankaferd blood stopper: demonstration of long-term histopathologic effects on
Bülent Saçak1, Zeynep D Akdeniz, Hakan Şirinoğlu
1aDepartment of Plastic Reconstructive and Aesthetic Surgery, Marmara University Faculty of Medicine, İstanbul bDepartment of Plastic Reconstructive and Aesthetic Surgery, Adana Numune Training and Research Hospital, Adana cDepartment of Plastic Reconstructive and Aesthetic Surgery, Kartal Training and Research Hospital dDepartment of Histology and Embryology, Marmara University Faculty of Medicine, İstanbul, Turkey.
Abstract:
Ankaferd blood stopper (ABS) (Ankaferd İlaç Kozmetik A.Ş., Turkey) is a medicinal plant extract, which is used in Turkish traditional medicine as a haemostatic agent. The aim of this study was to investigate the haemostatic effect of ABS in preventing microvascular leakage on an anastomosis site and to look into its long-term impact on vascular tissue. Twenty-one Wistar albino rats were randomly divided into three groups. The animals in the second and third groups were pretreated with acetylsalicylic acid. All of the right femoral arteries were divided and anastomosed in an end-to-end fashion. Following microvascular anastomosis, saline-soaked gauze tampons were applied in the first and second groups. In the third group, ABS-soaked tampons were applied to the anastomosis sites. The mean bleeding time of group 3 was significantly shorter than group 2 and group 1. Three weeks after the operation, there were aneurysms on all of the anastomosis sites in group 3 and none of the anastomoses were patent. Histologic examination demonstrated increased inflammatory cell infiltration, tunica media degeneration and contraction of tunica intima in group 3. This is the first study reporting the long-term effects of ABS on microvascular anastomosis. Contrary to previously reported studies, this agent is not appropriate for use on injured or anastomosed vessels.

